A large number of companies face the painful need to rightsize, but how does a business employ rightsizing processes to make it ‘Covid secure’?
What steps are needed to make the right, albeit difficult, decisions when it comes to staff structure for the future prosperity of a business? Louise McCosh, who heads up the internal and client-facing HR team as HR Director at professional services firm French Duncan LLP, explains.
When the Chancellor announced the introduction of the Job Retention Scheme, he was widely praised for the support he was offering to millions of people affected by the coronavirus pandemic.
Now that support is gradually coming to an end, a cliff edge looms. Research from the Institute for Public Policy Research (IPPR) suggests up to three million people could be at risk of losing their jobs, with two-thirds of these being sustainable in the longer term.
Pfizer has reported a 90% efficacy rate for its Covid-19 vaccine candidate in a limited number of test participants.
Michael Erman and Julie Steenhuisen from Reuters reported:
Pfizer Inc’s PFE.N experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus that has killed over a million people and battered the world’s economy.